Correction to Lancet Diabetes Endocrinol 2019; 7: 528-39

No authors listed

Published Erratum

No authors listed. Lancet Diabetes Endocrinol. 2019 Sep.

. 2019 Sep;7(9):e21.

doi: 10.1016/S2213-8587(19)30247-5. Epub 2019 Jul 15.

No abstract available

Erratum for

Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial.
Pieber TR, Bode B, Mertens A, Cho YM, Christiansen E, Hertz CL, Wallenstein SOR, Buse JB; PIONEER 7 investigators. Pieber TR, et al. Lancet Diabetes Endocrinol. 2019 Jul;7(7):528-539. doi: 10.1016/S2213-8587(19)30194-9. Epub 2019 Jun 9. Lancet Diabetes Endocrinol. 2019. PMID: 31189520 Clinical Trial.